Bayer and Monsanto are now worth less than Monsanto alone at the time of the Acquisition. The head of the group, questioned the meaningfulness of these Numbers and react cynically.
Elisabeth Dostert Elisabeth Dostert on Twitter send an E-Mail
The stock market impact the value of the chemical and Agro-Bayer is now less than the amount paid by Bayer in the past year for the US group Monsanto. Although Bayer and his partner company Janssen Pharmaceuticals could draw in the case of the anticoagulant Xarelto to the start of the week a comparison of around 25 000 claimants, the share price fell, but more. Early Tuesday afternoon, the papers of Bayer cost 56,70 Euro per share, corresponding to a market capitalization of close to € 53 billion or the equivalent of almost 60 billion dollars. For Monsanto, Bayer had paid 63 billion dollars.
The recent defeat of the German group suffered last week, as the jury of a court in the USA decided in the first Phase of the process is that the weed killer Roundup with the active ingredient glyphosate have “significantly” contributed to the cancer of the plaintiff, Ed Hardeman. The second Phase, in which it is checked whether Monsanto knowingly risks has been concealed. Hard Mans case, is considered a trendsetter for a couple of Hundred procedures from the competent judge Vince Chhabria pending, in total, there are in the United States now has more than 11 200 suits due to glyphosate.
Bayer CEO Werner Baumann has weakness of his own explanation for the course. “When it comes to rate uncertainties, tends to Exaggerate the stock market,” he says a few days ago, the Frankfurter General Sunday newspaper. “The good Constitution of the company, the outstanding growth prospects, the profitability, the Portfolio – all of which I see only very incomplete at the current market value of reflected,” said Baumann in the Interview. The “only Good” at the lawsuit said, cynically, that they are acting as a poison pill, the potential attacker deterrent. “Otherwise, Bayer would have been a takeover candidate in view of the shrunken stock market value.”
